Does Alzheimer's disease stem in the gastrointestinal system?

Life Sci. 2021 Dec 15:287:120088. doi: 10.1016/j.lfs.2021.120088. Epub 2021 Oct 29.

Abstract

Over the last decades, our knowledge of the key pathogenic mechanisms of Alzheimer's disease (AD) has dramatically improved. Regarding the limitation of current therapeutic strategies for the treatment of multifactorial diseases, such as AD, to be translated into the clinic, there is a growing trend in research to identify risk factors associated with the onset and progression of AD. Here, we review the current literature with a focus on the relationship between gastrointestinal (GI)/liver diseases during the lifespan and the incidence of AD, and discuss the possible mechanisms underlying the link between the diseases. We also aim to review studies evaluating the possible link between the chronic use of the most common GI medications and the future risk of AD development.

Keywords: Alzheimer's disease; Dementia; Gastrointestinal disease; Liver disease; Microbiota; Nerve degeneration.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / metabolism*
  • Animals
  • Brain / metabolism*
  • Brain-Gut Axis / physiology*
  • Gastrointestinal Diseases / epidemiology
  • Gastrointestinal Diseases / metabolism*
  • Gastrointestinal Tract / metabolism*
  • Humans
  • Liver Diseases / epidemiology
  • Liver Diseases / metabolism*
  • Risk Factors